Consumers Against High Drug Prices
Exposing The FDA's Regulatory Quagmire
CoQ10 Wars
Assembly Line Medicine
Collapsing Within Itself
Intolerable Delays!
"Unsustainable" Cancer Drug Prices
How Government Treated Those For Whom We Now Celebrate Holidays
Horrific Conditions Inside Drug Factories
When "Rules" Are Broken
Federal Death Panels
Science by Ambush
The Looming Doctor Shortage
Former FDA Commissioner Admits Risk of Bureaucratic Delay
FDA Says Walnuts Are Illegal Drugs
The FDA's Most Heinous Drug Approval
No Real Healthcare Cost Crisis
FDA Delay of One Drug Causes 82,000 Lost Life-Years
Deadly FDA Neglect
How Much More FDA Abuse Can Americans Tolerate?
Drug Company Pleads Guilty to Health Fraud
Why American Healthcare is Headed for Collapse
The Generic Drug Rip-off
Ending the Atrocities
Millions of Needless Deaths
Would You Tolerate This Abuse?
The FDA Indicts Itself
The FDA's Cruel Hoax
Fish Oil Now Available by Prescription!
FDA Threatens to Raid Cherry Orchards
Inside the FDA's Brain
FDA Fails to Protect Domestic Drug Supply
FDA Permits New Fish Oil Health Claim
FDA Approves Deadly Drugs, Delays Lifesaving Therapies
The $50.00 Toll Bridge
Dangerous Medicine
Cardiologists Overlook Lifesaving Discovery
What You Don’t Know About Blood Sugar
Jerry Falwell Attacks Life Extension Foundation
Life Extension Achieves "Impossible" Victory in the U.S. House of Representatives
Fighting the FDA
Patient Advocates Sue FDA Over Drug Access
FDA's Lethal Impediment
Don't Blame the Doctors
One Man's Ten-Year Ordeal With Prostate Cancer
A New Day At FDA?
The FDA Versus the American Consumer
Supreme Court Roundup
The Lethal Information Gap
Consumer Rape
Dying From Deficiency
Are Offshore Drugs Dangerous?
Drugs the FDA Says You Can't Have
Does Cholesterol Cause Artery Disease?
What's Wrong with the FDA
FDA Suffers Second Massive Legal Defeat in Pearson v. Shalala
FDA Loses Case Against Compounding Pharmacies on First Amendment Grounds
Ending The Cancer Bureaucracy
Victory in the House and Senate
Life Extension Wins in the House and Senate
Congress Recognizes The Prescription Drug Problem
Americans are getting Healthier... But the FDA Remains a Major Impediment
Are We to Become Serfs of the Drug Monopoly?
A Glorious Victory Over FDA Tyranny
The Great American Rip-Off
The Plague Of FDA Regulation
Health Costs to Double Is there a free-market solution?
The FDA versus Folic Acid
They Want You Brain Dead
Life Extension vs. the FDA a Hollow Victory: Why the Agency's Approval of Ribavirin is Inadequate

The $50.00 Toll Bridge

The FDA has said that it does not plan to stop individuals from importing their medications for personal use, so the opportunity for offshore companies to counterfeit has never been greater. As we revealed several months ago, it is American pharmacies that are more likely to be targeted by sellers of counterfeit drugs, because the high profit margins in this country make the selling of bogus medications super-profitable. Unlike the situation with Canadian drugs, where there is no evidence to demonstrate a potential danger, serious side effects have occurred after Americans were exposed to adulterated drugs purchased in US pharmacies.12,13

Drug money has overwhelmed logic, decency, and the oaths that federal officials took when being sworn into office. This is a sad day for the American citizenry, as the government has performed a public disservice that flies in the face of all we know about the virtues of a free marketplace.

The Public Is Not Fooled

The FDA’s deception about the purported “dangers” of Canadian drugs gave elected officials an excuse for denying Americans access to them.

But the American public is not that gullible. On October 20, 2003, the results of a randomized survey of more than 1,000 people conducted by the Washington Post and ABC News found that 66% of Americans favor legalizing prescription drug imports.10
A much larger survey of more than 160,000 people produced the following result:11

Should Americans be allowed to import lower-priced prescription
drugs from Canada?





When the same question was placed on the Life Extension website, 97% favored allowing Americans to import lower-priced drugs from Canada. This is not surprising, considering Life Extension members’ contempt for the FDA.

The vast majority of Americans favor legalizing the importation of lower-priced drugs from Canada. That the import provision was intentionally left out of the Medicare bill is an utter disgrace to the democratic process.

Today’s Plight
The federal government has erected an artificial toll bridge that forces consumers to subsidize exorbitant drug prices. Dr. Benjamin Rush, a signer of the Declaration of Independence, predicted this when he stated:

“Unless we put medical freedom into the Constitution, the time will come when medicine will organize into an undercover dictatorship . . . to restrict the art of healing to one class of men and deny equal privileges to others . . . ”15

The pharmaceutical industry has become the “undercover dictatorship” that Dr. Rush said would manifest without a constitutional guarantee of medical freedom. Drug companies not only exert tremendous control over which medications are allowed on the market,16 but they also have succeeded in dictating where Americans may purchase these medications, thereby keeping out lower-priced competition.

Pharmaceutical companies say high prices are needed to pay for research. The facts are that many drugs are dangerous and only minimally effective.17 Sky-high prices have enabled drug companies to aggressively market their mediocre products to doctors and the public, while lavishing huge dollars to buy the political influence needed to stave off regulatory interference.

Drug company research consists of identifying patentable molecules that show some effect against a disease. After hundreds of millions of dollars are spent gaining FDA approval, the new drug is then massively promoted to create a cash cow for the duration of the patent. This proven formula for economic success has not resulted in cures being found for our most feared diseases, but it has consistently produced billions of dollars in profits for the pharmaceutical giants.

The new Medicare bill guarantees gargantuan tax dollars to the drug companies for their overpriced products, with limited consumer benefit. A free-market approach, on the other hand, would force the drug companies to develop better products because there would be no government guarantee that mediocre drugs would be paid for by tax dollars.

Defending the Consumer
The Life Extension Buyers Club is battling the drug industry behemoth because we believe that today’s FDA-protected monopoly discourages innovation. Those with novel disease treatments are censored by an overbearing FDA, which acts to protect the economic interests of the entrenched drug industry at the expense of the consumer and taxpayer.

Medical progress is hindered when the government guarantees outrageous profits to companies that fail to develop real breakthroughs, while making it too expensive for those with novel lifesaving therapies to compete in the marketplace.

Ordinary Americans pay the equivalent of a $50 bridge toll every time they buy a prescription drug. As a customer of the Life Extension Buyers Club, you help support a voice for the consumer in a political environment subjugated by vast amounts of drug money.

For longer life,


William Faloon

How Drug Companies Influence Politicians, the FDA, and the Public

On June 9, 2003, the chairman of the House Subcommittee on Human Rights and Wellness provided the following data to show how pharmaceutical companies are infiltrating multiple levels of government, the FDA, the media, and the public by spending millions of dollars on influence-peddling campaigns. The following data reveal some expenditures that were being considered by the pharmaceutical industry:14

  • $72.7 million for advocacy at the federal level, aimed mainly at Congress

  • $48.7 million for advocacy at the state level
  • $17.5 million to fight price controls and protect patent rights in foreign countries and in trade negotiations
  • $15.8 million to fight a union-driven get-out-the-vote initiative in Ohio that would lower drug prices for people who have no insurance to cover drug costs
  • $12.3 million to develop coalitions and strategic alliances with doctors, patients, universities, and influential members of minority groups
  • $9.5 million for public relations, including $1 million for inside-the-Beltway advertising
  • $4.9 million to lobby the FDA
  • $3.1 million to retain more than 60 lobbyists in the 50 states
  • Several million dollars to foster ties with groups like the National Black Caucus of State Legislators, the National Hispanic Caucus of State Legislators, and the National Medical Association, which represents the interests of African-American doctors
  • $2 million or more in payments to research and policy organizations to build “intellectual capital” and generate a higher
    volume of messages from credible sources sympathetic to the industry
  • $1.3 million for local publicity
  • $1 million to “change the Canadian health care system”
  • $1 million for an “intellectual echo chamber” of economists to oppose, in written articles and testimony, federal price-control regulations
  • $500,000 for efforts to “educate and activate” Hispanic-Latino organizations on the state and federal levels
  • $550,000 for placement of op-ed pieces and articles by third parties.

Clearly, these formidable expenditures are designed to eliminate American consumers’ freedom of choice and block their access to lower-priced Canadian and European drugs, while increasing drug manufacturers’ profits.

What You Can Do

You can express your outrage over the new Medicare bill by writing or emailing your US representative and senators. Those who believe that prescription drugs sold in Canada and Europe are safe should demand that their members of Congress change the law to enable Americans to purchase lower-cost medications from these other jurisdictions.

To find out the name of your members of Congress and email them directly, log on to the following congressional websites: and


Continued on Page 3 of 3